Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET

被引:6
|
作者
Zhang, Qi [1 ]
Fan, Chunqiu [2 ]
Wang, Luyao [3 ]
Li, Taoran [4 ]
Wang, Min [3 ]
Han, Ying [2 ,5 ,6 ,7 ]
Jiang, Jiehui [3 ,8 ]
机构
[1] Shanghai Univ, Sch Commun & Informat Engn, Shanghai 200444, Peoples R China
[2] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China
[3] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
[4] Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
[5] Hainan Univ, Sch Biomed Engn, Haikou 570228, Peoples R China
[6] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing 100053, Peoples R China
[7] Natl Clin Res Ctr Geriatr Dis, Beijing 100053, Peoples R China
[8] Nucl Med & Mol Imaging Key Lab Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China
基金
美国国家卫生研究院;
关键词
Cognitively unimpaired; FDG PET; Kaplan-Meier analysis; Neurodegeneration; Posterior cingulate cortex; ASSOCIATIONS; IMPAIRMENT; BIOMARKERS; DIAGNOSIS; FRAMEWORK; IMPROVES; DECLINE; TAU; FDG; CSF;
D O I
10.1007/s11357-023-00897-0
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Amyloid-ss (A ss) and tau are important biomarkers to predict the progression of cognitively unimpaired (CU) to dementia due to Alzheimer's disease (AD), according to the diagnosis framework from the US National Institute on Aging and the Alzheimer's Association (NIA-AA). However, it is clinically difficult to predict those subjects who were already with A ss positive (A +) or tau positive (T +). As a typical characteristic of neurodegeneration in the diagnosis framework, the hypometabolism of the posterior cingulate cortex (PCC) has significant clinical value in the early prediction and prevention of AD. In this paper, we proposed the glucose metabolism in the PCC as a biomarker supplement to A ss and tau biomarkers. First, we calculated the standard uptake value ratio (SUVR) of PCC based on fluorodeoxyglucose positron emission computed tomography (FDG PET) imaging. Secondly, we performed Kaplan-Meier (KM) survival analyses to explore the predictive performance of PCC SUVR, and the hazard ratio (HR) was calculated. Finally, we performed Pearson correlation analyses to explore the physiological significance of PCC SUVR. As a result, the PCC SUVR showed a consistent downward trend along the AD continuum. KM analyses showed better predictive performance when we combined PCC SUVR with cerebro-spinal fluid (CSF) A ss(42) (from HR= 2.56 to 3.00 within 5 years; from HR = 2.76 to 4.20 within 10 years) and ptau-181 (from 2.83 to 3.91 within 5 years; from HR = 2.32 to 4.17 within 10 years). There was a slight correlation between A ss(42)/A ss(40) and PCC SUVR (r = 0.14, p = 0.02). In addition, several cognition scales were also correlated to PCC SUVR (from r = -0.407 to 0.383, p < 0.05). Our results showed that glucose metabolism in PCC may be a potential biomarker supplement to the A ss and tau biomarkers to predict the progression of CU to AD.
引用
收藏
页码:1407 / 1420
页数:14
相关论文
共 48 条
  • [31] Assessing the metabolism of the olfactory circuit by use of 18F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer's disease or frontotemporal dementia
    Loewenstein, Daniel S. L.
    van Grinsven, Max
    de Pont, Cecile
    Dautzenberg, Paul L. J.
    van Strien, Astrid M.
    Henssen, Dylan
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [32] The impact of amyloid burden on glucose metabolism in Alzheimer's disease: Evidence from [11C]PIB and [18F]FDG PET imaging for a differential effect along the anterior-posterior axis
    Furst, Ansgar
    Mormino, Elizabeth
    Lal, Rayhan
    Rabinovici, Gil
    Patel, Paras
    Madison, Cindee
    Baker, Suzanne
    Miller, Bruce
    Jagust, William
    NEUROLOGY, 2008, 70 (11) : A449 - A449
  • [33] RETRACTED: The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between 18F-FDG PET and 123I-IMP SPECT (Retracted Article)
    Chiba, Yuhei
    Fujishiro, Hiroshige
    Iseki, Eizo
    Kasanuki, Koji
    Sato, Kiyoshi
    NEUROSCIENCE LETTERS, 2018, 683 : 168 - 173
  • [34] A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET
    Etminani, Kobra
    Soliman, Amira
    Davidsson, Anette
    Chang, Jose R.
    Martinez-Sanchis, Begona
    Byttner, Stefan
    Camacho, Valle
    Bauckneht, Matteo
    Stegeran, Roxana
    Ressner, Marcus
    Agudelo-Cifuentes, Marc
    Chincarini, Andrea
    Brendel, Matthias
    Rominger, Axel
    Bruffaerts, Rose
    Vandenberghe, Rik
    Kramberger, Milica G.
    Trost, Maja
    Nicastro, Nicolas
    Frisoni, Giovanni B.
    Lemstra, Afina W.
    van Berckel, Bart N. M.
    Pilotto, Andrea
    Padovani, Alessandro
    Morbelli, Silvia
    Aarsland, Dag
    Nobili, Flavio
    Garibotto, Valentina
    Ochoa-Figueroa, Miguel
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (02) : 563 - 584
  • [35] Mild Cognitive Impairment with a High Risk of Progression to Alzheimer's Disease Dementia (MCI-HR-AD): Effect of Souvenaid® Treatment on Cognition and 18F-FDG PET Scans
    Manzano Palomo, Maria Sagrario
    Anaya Caravaca, Belen
    Balsa Breton, Maria Angeles
    Muniz Castrillo, Sergio
    de la Morena Vicente, Asuncion
    Castro Arce, Eduardo
    Alves Perez, Maria Teresa
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2019, 3 (01) : 95 - 102
  • [36] A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET
    Kobra Etminani
    Amira Soliman
    Anette Davidsson
    Jose R. Chang
    Begoña Martínez-Sanchis
    Stefan Byttner
    Valle Camacho
    Matteo Bauckneht
    Roxana Stegeran
    Marcus Ressner
    Marc Agudelo-Cifuentes
    Andrea Chincarini
    Matthias Brendel
    Axel Rominger
    Rose Bruffaerts
    Rik Vandenberghe
    Milica G. Kramberger
    Maja Trost
    Nicolas Nicastro
    Giovanni B. Frisoni
    Afina W. Lemstra
    Bart N. M. van Berckel
    Andrea Pilotto
    Alessandro Padovani
    Silvia Morbelli
    Dag Aarsland
    Flavio Nobili
    Valentina Garibotto
    Miguel Ochoa-Figueroa
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 563 - 584
  • [37] Cortical amyloid load and glucose metabolism in Alzheimer's disease and mild cognitive impairment with [11C]PIB- and [18F]FDG-PET imaging
    Hatashita, S.
    Yamasaki, H.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S278 - S278
  • [38] Study of Tau Deposition in Patients of Alzheimer's Disease with [18F]-APN-1607 PET tracer and Its Relationship with Cerebral Glucose Metabolism
    Lu, Jiaying
    Bao, Weiqi
    Li, Ming
    Li, Ling
    Zhang, Zhengwei
    Song, Jiong
    Alberts, Ian
    Brendel, Matthias
    Cumming, Paul
    Zuo, Chuantao
    Guan, Yihui
    Zhao, Qianhua
    Rominger, Axel
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Visual assessment of 11C-PIB PET and 18F-FDG PET for detection of amyloid burden and abnormal metabolism among cognitively normal middle-aged adults with high risks for Alzheimer's disease
    Xu, Guofan
    Johnson, Sterling
    Christian, Brad
    Asthana, Sanjay
    Sager, Mark
    Hall, Lance
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [40] Le body dementia and Posterior cortical variant of Alzheimer's disease: Distinguishing imaging patterns based on 18F-FDG PET/CT and 99mTc-TRODAT SPECT scan
    Gupta, Vanshika
    Verma, Ritu
    Ranjan, Rajeev
    Belho, Ethel
    Mahajan, Harsh
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60